100% Quality Guarantee
PhD-Level Technical Support
Key Features

APC Anti-Human CD95 Antibody [DX2] (AGEL1839)

SKU AGEL1839
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FC
Reactivity Human
Host Species Mouse
Isotype IgG2a,k
Clone DX2
Conjugation APC
€132 - €585

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

APC Anti-Human CD95 Antibody [DX2]

The Human CD95 Monoclonal Antibody (APC-conjugated) DX2 (AG-EL1839) is a powerful tool for researchers studying CD95, a cell surface receptor crucial for apoptosis signaling in immune cells. This monoclonal antibody, derived from mouse hybridoma cells, exhibits high specificity and affinity for human CD95, making it ideal for flow cytometry studies. By binding to the CD95 antigen, this antibody allows for precise detection and quantification of CD95-expressing cells in diverse biological samples.CD95, also known as Fas receptor, is a key player in programmed cell death pathways and immune system regulation. Its dysregulation has been implicated in various diseases, including cancer and autoimmune disorders.

By targeting CD95 with this monoclonal antibody, researchers can gain insights into the role of CD95 in disease development and progression. Moreover, understanding the mechanisms by which CD95 impacts cell survival and death processes can provide valuable information for developing targeted therapies in oncology and immunology research.Overall, the Human CD95 Monoclonal Antibody (APC-conjugated) DX2 (AG-EL1839) offers a reliable tool for investigating the functions and implications of CD95 in health and disease, ultimately contributing to advancements in therapeutic approaches and disease management strategies.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose